Abstract
Glucagon-like peptide 2 (GLP-2) is an intestinal epithelium-specific growth factor. However, its protective effects and related mechanism on the small intestine injured by ischemia–reperfusion (I/R) in mice remain unclear. This study aimed to reveal the effects of GLP-2 and its functional relationship with uncoupling protein 2 (UCP2) on the small intestine after I/R injury in mice. Male Balb/c mice were given GLP-2 (250 μg/kg/day, ip) for 3 days and underwent 30 min of superior mesenteric artery occlusion followed by 1 hr of reperfusion on day 4. Histological damage, bacterial translocation, diamine oxidase, and malondialdehyde level were assessed, and UCP2 expression was measured by immunohistochemistry and Western blot. GLP-2 attenuated the intestinal histological damage caused by I/R and increased the villous height by 28% and the crypt depth by 10%, respectively. Compared to the I/R group, diamine oxidase activity was increased, the incidence of bacterial translocation and malondialdehyde level were decreased, and UCP2 expression was increased in GLP-2-treated mice. GLP-2 protected the small intestine from I/R injury and increased UCP2 expression. These results suggested that effects of GLP-2 should be related to the upregulation of mitochondrial UCP2, which antagonized reactive oxygen species production.
Similar content being viewed by others
References
Swank GM, Deitch EA: Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 20(4):411–417, 1996
Sheth P, Seth A, Thangavel M, Basuroy S, Rao RK: Epidermal growth factor prevents acetaldehyde-induced paracellular permeability in Caco-2 cell monolayer. Alcohol Clin Exp Res 28(5):797–804, 2004
Chen K, Okuma T, Okamura K, Tabira Y, Kaneko H, Miyauchi Y: Insulin-like growth factor-I prevents gut atrophy and maintains intestinal integrity in septic rats. JPEN J Parenter Enteral Nutr 19(2):119–124, 1995
Drucker DJ, Erlich P, Asa SL, Brubaker PL: Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93(15):7911–7916, 1996
Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ: Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 273(1, Pt 1):E77–E84, 1997
Benjamin MA, McKay DM, Yang PC, Cameron H, Perdue MH: Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 47(1):112–119, 2000
Scott RB, Kirk D, MacNaughton WK, Meddings JB: GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 275(5, Pt 1):G911–G921, 1998
Drucker DJ, Yusta B, Boushey RP, DeForest L, Brubaker PL: Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am J Physiol 276(1, Pt 1):G79–G91, 1999
Alavi K, Schwartz MZ, Palazzo JP, Prasad R: Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. J Pediatr Surg 35(6):847–851, 2000
Tavakkolizadeh A, Shen R, Abraham P, et al.: Glucagon-like peptide 2: A new treatment for chemotherapy-induced enteritis. J Surg Res 91(1):77–82, 2000
Fleury C, Sanchis D: The mitochondrial uncoupling protein-2: current status[J] . Int J Biochem Cell Biol 31(11):1261–1278, 1999
Fleury C, Neverova M, Collins S, et al.: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15(3):269–272, 1997
Duval C, Negre-Salvayre A, Dogilo A, Salvayre R, Penicaud L, Casteilla L: Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. Biochem Cell Biol 80(6):757–764, 2002
Arsenijevic D, Onuma H, Pecqueur C, et al.: Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26(4):435–439, 2000
Echtay KS, Roussel D, St-Pierre J, et al.: Superoxide activates mitochondrial uncoupling proteins. Nature 415(6867):96–99, 2002
Kouris GJ, Liu Q, Rossi H, et al.: The effect of glucagon-like peptide 2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis. Am J Surg 181(6):571–575, 2001
Li JY, Sun D, Lu Y, et al.: Change in intestinal function in sepsis in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16(6):352–354, 2004 (Chinese)
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254, 1976
Taniguchi E, Harada M, Kawaguchi T, et al.: Expression of uncoupling protein-2 in biliary epithelial cells in primary biliary cirrhosis. Liver 22(6):451–458, 2002
Pecqueur C, Alves-Guerra MC, Gelly C, et al.: Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem 276(12):8705–8712, 2001
Dowdall JF, Winter DC, Bouchier-Hayes DJ: Inosine modulates gut barrier dysfunction and end organ damage in a model of ischemia-reperfusion injury. J Surg Res 108(1):61–68, 2002
Eror AT, Stojadinovic A, Starnes BW, Makrides SC, Tsokos GC, Shea-Donohue T: Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol 90(2):266–275, 1999
Zhang C, Sheng ZY, Hu S, Gao JC, Yu S, Liu Y: The influence of apoptosis of mucosal epithelial cells on intestinal barrier integrity after scald in rats. Burns 28(8):731–737, 2002
Drucker DJ: Glucagon-like peptides. Diabetes 47(2):159–169, 1998
Rajeevprasad R, Alavi K, Schwartz MZ: Glucagonlike peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury. J Pediatr Surg 35(11):1537–1539, 2000
Prasad R, Alavi K, Schwartz MZ: Glucagon-like peptide 2 analogue enhances intestinal mucosal mass following ischemia and reperfusion. J Pediatr Surg 35(2):357–359, 2000
Peng X, Yan H, You Z, Wang P, Wang S: Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns 30(2):135–139, 2004
Chang T, Lu R, Tsai L: Glutamine ameliorates mechanical obstruction-induced intestinal injury. J Surg Res 95(2):133–140, 2001
Prabhu R, Thomas S, Balasubramanian KA: Oral glutamine attenuates surgical manipulation-induced alterations in the intestinal brush border membrane. J Surg Res 115(1):148–156, 2003
Ikeda S, Zarzaur BL, Johnson CD, Fukatsu K, Kudsk KA: Total parenteral nutrition supplementation with glutamine improves survival after gut ischemia-reperfusion. JPEN J Parenter Enteral Nutr 26(3):169–173, 2002
Negre-Salvayre A, Hirtz C, Carrera G, et al.: A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11(10):809–815, 1997
Argiles JM, Busquets S, Lopez-Soriano FJ: The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 293(4):1145–1152, 2002
Richard D, Clavel S, Huang Q, Sanchis D, Ricquier D: Uncoupling protein 2 in the brain: distribution and function. Biochem Soc Trans 29 (Pt 6):812–817, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guan, L., Gong, D., Tian, N. et al. Uncoupling Protein 2 Involved in Protection of Glucagon–like Peptide 2 in Small Intestine with Ischemia–Reperfusion Injury in Mice. Dig Dis Sci 50, 554–560 (2005). https://doi.org/10.1007/s10620-005-2474-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2474-3